Beta-blockers curb death risk in high-risk STEMI patients

02/17/2013 | PhysiciansBriefing.com

A study in The American Journal of Cardiology found beta-blocker treatment may help cut long-term mortality in high-risk ST-segment elevation myocardial infarction patients. However, the therapy did not appear to benefit lower-risk patients, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA